Physician

Gurdeep Chhabra

According to 2025 Medicare claims, Gurdeep Chhabra (NPI: 1336173277) practices hematology/oncology in the Lexington Park, MD market, with the plurality of this provider's patient population coming from St. Marys, MD. This provider's primary affiliated billing organization is MEDSTAR MEDICAL GROUP - SOUTHERN MARYLAND LLC (NPI: 1831592211; TIN: 462691028) and primary practice location at 20619-4018.

Chhabra's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 692 traditional Medicare patients, billed 189,141 HCPCS/CPT codes, and received $2,576,062 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,492 prescription claims across 299 beneficiaries totaling $3,424,998 in drug costs, led by Xtandi (Enzalutamide). DME data shows 13 claims. Open Payments data shows 78 records totaling $2,317. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $726,885 to $3,424,998. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	610	237,751	$2,114,646
2016	681	195,332	$2,346,036
2017	686	166,355	$2,437,297
2018	715	174,254	$2,435,107
2019	708	144,432	$2,291,237
2020	690	162,813	$2,602,964
2021	694	146,197	$2,562,937
2022	708	183,852	$3,282,316
2023	768	187,327	$2,786,754
2024	692	189,141	$2,576,062

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	131	857	$726,885
2016	146	1,108	$1,148,470
2017	177	1,132	$973,822
2018	170	1,038	$1,416,800
2019	183	1,093	$2,015,583
2020	170	1,123	$2,169,769
2021	188	1,115	$2,744,824
2022	201	1,305	$3,020,126
2023	222	1,047	$2,355,920
2024	299	1,492	$3,424,998

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	46	$27,682
2016	N/R	11	$9,576
2017	N/R	N/R	N/R
2018	N/R	42	$8,023
2019	N/R	57	$5,547
2020	N/R	11	$208
2021	N/R	22	$710
2022	N/R	N/R	N/R
2023	N/R	11	$3,783
2024	N/R	13	$579

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	184	565	$144
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	498	1,330	$99
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	258	604	$13
36415	Insertion of needle into vein for collection of blood sample	472	2,128	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	342	1,493	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	60	1,800	$791,228
Revlimid	Lenalidomide	24	672	$426,723
Tagrisso	Osimertinib Mesylate	17	510	$320,344
Imbruvica	Ibrutinib	19	544	$314,236
Lenalidomide	Lenalidomide	21	588	$206,097

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	13	$579

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	78	$2,317	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gurdeep Chhabra?

Tedicare shows public-source Medicare data for Gurdeep Chhabra (NPI 1336173277), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gurdeep Chhabra have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gurdeep Chhabra?

Gurdeep Chhabra is linked to MEDSTAR MEDICAL GROUP - SOUTHERN MARYLAND LLC (billing NPI 1831592211) in the available physician profile data.

Does Gurdeep Chhabra have Open Payments data?

Gurdeep Chhabra has 78 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.